Claims
- 1. A 6-phenyl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepine compound of the formula: ##STR40## wherein R.sub.1 is hydrogen or a halogen atom, R.sub.2 is hydrogen or an alkyl group with 1 to 4 carbon atoms,
- R.sub.3 is hydrogen, or a halogen
- the structural part A-B is the group, --CH.dbd.N--,
- and Y-Z is the group >C.dbd.N-- or >C.dbd.N(.fwdarw.O), their optical isomers and their pharmaceutically acceptable salts.
- 2. A compound according to claim 1 wherein any halogen atom present has an atomic weight of 9 to 80.
- 3. A compound according to claim 1 wherein Y--Z is >C.dbd.N--.
- 4. A compound according to claim 3 wherein R.sub.1 is chlorine, bromine or fluorine, R.sub.2 is hydrogen and R.sub.3 is hydrogen or chlorine.
- 5. A compound according to claim 4 wherein R.sub.1 is chlorine, bromine or fluorine.
- 6. A compound according to claim 4 where R.sub.1 is chlorine and R.sub.3 is chlorine.
- 7. A compound according to claim 6 which is 6-(o-chlorophenyl)-8-chloro-4H-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepine.
- 8. A compound according to claim 1 which is 6-(o-chlorophenyl)-8-chloro-4H-s-triazolo-(4,3-a)-pyrido-(2,3-f-)-(1,4)-diazepine 5-oxide.
- 9. A compound according to claim 1 which is 6-phenyl-8-bromo-4H-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepine.
- 10. A compound according to claim 1 which is 6-(o-fluorophenyl)-8-chloro-4H-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepine.
- 11. A compound according to claim 1 which is 6-phenyl-8-chloro-4H-s-triazolo-(4,3-a)-pyrido-(2,3-f)-(1,4)-diazepine.
- 12. A composition having stress relieving activity comprising an effective amount for such activity of a compound of claim 1 in a pharmaceutically acceptable carrier.
- 13. A method of relieving stress in a mammal comprising administering to the mammal an amount of the compounds of claim 1 sufficient to relieve stress.
- 14. A method according to claim 13 wherein the compound is administered orally.
- 15. A method according to claim 13 wherein the compound is administered intravenously.
- 16. A method according to claim 13 wherein the compound is administered sublingually.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8372/75 |
Nov 1975 |
ATX |
|
Parent Case Info
This is a division, of application Ser. No. 735,894 filed Oct. 26, 1976, now U.S. Pat. No. 4,110,455.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4073792 |
von Bebenburg et al. |
Feb 1978 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
2416608 |
Oct 1974 |
DEX |
Divisions (1)
|
Number |
Date |
Country |
Parent |
735894 |
Oct 1976 |
|